Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Retained Earnings (2021 - 2025)

Bioregenx's Retained Earnings history spans 5 years, with the latest figure at -$37.1 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$37.1 million for Q4 2025, down 4.34% from a year ago — trailing twelve months through Dec 2025 was -$37.1 million (down 4.34% YoY), and the annual figure for FY2025 was -$37.1 million, down 4.34%.
  • Retained Earnings for Q4 2025 was -$37.1 million at Bioregenx, down from -$36.1 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $99.0 in Q1 2024 to a low of -$37.1 million in Q4 2025.
  • The 5-year median for Retained Earnings is -$3.4 million (2023), against an average of -$12.7 million.
  • Peak annual rise in Retained Earnings hit 100.0% in 2024, while the deepest fall reached 3776120.28% in 2024.
  • Year by year, Retained Earnings stood at -$2.8 million in 2021, then decreased by 4.19% to -$2.9 million in 2022, then soared by 99.97% to -$942.0 in 2023, then crashed by 3776120.28% to -$35.6 million in 2024, then dropped by 4.34% to -$37.1 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$37.1 million, -$36.1 million, and -$36.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.